CHEMUNG FINANCIAL CORP (CHMG)
US1640241014 - Common Stock
Overall CHMG gets a fundamental rating of 4 out of 10. We evaluated CHMG against 411 industry peers in the Banks industry. Both the profitability and the financial health of CHMG get a neutral evaluation. Nothing too spectacular is happening here. CHMG is valued correctly, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
CHMG had positive earnings in the past year.
In the past year CHMG had a positive cash flow from operations.
In the past 5 years CHMG has always been profitable.
In the past 5 years CHMG always reported a positive cash flow from operatings.
1.2 Ratios
CHMG has a Return On Assets of 0.92%. This is comparable to the rest of the industry: CHMG outperforms 54.50% of its industry peers.
CHMG has a Return On Equity of 12.81%. This is amongst the best in the industry. CHMG outperforms 82.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.92% | ||
| ROE | 12.81% | ||
| ROIC | N/A |
ROA(3y)1.03%
ROA(5y)0.96%
ROE(3y)14.2%
ROE(5y)12.16%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
CHMG has a Profit Margin of 25.25%. This is comparable to the rest of the industry: CHMG outperforms 56.69% of its industry peers.
CHMG's Profit Margin has been stable in the last couple of years.
The Operating Margin and Gross Margin are not available for CHMG so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | 25.25% | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y3.28%
PM growth 5Y1.45%
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
CHMG does not have a ROIC to compare to the WACC, probably because it is not profitable.
CHMG has more shares outstanding than it did 1 year ago.
CHMG has less shares outstanding than it did 5 years ago.
CHMG has a better debt/assets ratio than last year.
2.2 Solvency
The Debt to FCF ratio of CHMG is 0.10, which is an excellent value as it means it would take CHMG, only 0.10 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 0.10, CHMG belongs to the best of the industry, outperforming 86.37% of the companies in the same industry.
A Debt/Equity ratio of 0.02 indicates that CHMG is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.02, CHMG belongs to the top of the industry, outperforming 85.64% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.02 | ||
| Debt/FCF | 0.1 | ||
| Altman-Z | N/A |
ROIC/WACCN/A
WACC18.25%
2.3 Liquidity
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | N/A | ||
| Quick Ratio | N/A |
3. Growth
3.1 Past
The earnings per share for CHMG have decreased strongly by -13.56% in the last year.
Measured over the past 5 years, CHMG shows a small growth in Earnings Per Share. The EPS has been growing by 6.95% on average per year.
CHMG shows a small growth in Revenue. In the last year, the Revenue has grown by 3.55%.
Measured over the past years, CHMG shows a small growth in Revenue. The Revenue has been growing by 3.45% on average per year.
EPS 1Y (TTM)-13.56%
EPS 3Y9.67%
EPS 5Y6.95%
EPS growth Q2Q-48.73%
Revenue 1Y (TTM)3.55%
Revenue growth 3Y5.61%
Revenue growth 5Y3.45%
Revenue growth Q2Q-9.59%
3.2 Future
Based on estimates for the next years, CHMG will show a small growth in Earnings Per Share. The EPS will grow by 1.91% on average per year.
Based on estimates for the next years, CHMG will show a small growth in Revenue. The Revenue will grow by 4.03% on average per year.
EPS Next Y-9.59%
EPS Next 2Y1.91%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year0.11%
Revenue Next 2Y4.03%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 8.02 indicates a reasonable valuation of CHMG.
Compared to the rest of the industry, the Price/Earnings ratio of CHMG indicates a somewhat cheap valuation: CHMG is cheaper than 70.56% of the companies listed in the same industry.
CHMG's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 25.20.
With a Price/Forward Earnings ratio of 8.87, the valuation of CHMG can be described as very reasonable.
Based on the Price/Forward Earnings ratio, CHMG is valued a bit cheaper than 70.80% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of CHMG to the average of the S&P500 Index (21.63), we can say CHMG is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.02 | ||
| Fwd PE | 8.87 |
4.2 Price Multiples
Based on the Price/Free Cash Flow ratio, CHMG is valued a bit cheaper than the industry average as 71.53% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 6.62 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)1.15
EPS Next 2Y1.91%
EPS Next 3YN/A
5. Dividend
5.1 Amount
CHMG has a Yearly Dividend Yield of 2.83%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 3.86, CHMG is paying slightly less dividend.
Compared to an average S&P500 Dividend Yield of 2.44, CHMG has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.83% |
5.2 History
The dividend of CHMG has a limited annual growth rate of 3.63%.
CHMG has paid a dividend for at least 10 years, which is a reliable track record.
CHMG has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)3.63%
Div Incr Years0
Div Non Decr Years13
5.3 Sustainability
23.36% of the earnings are spent on dividend by CHMG. This is a low number and sustainable payout ratio.
CHMG's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP23.36%
EPS Next 2Y1.91%
EPS Next 3YN/A
CHEMUNG FINANCIAL CORP
NASDAQ:CHMG (4/26/2024, 2:14:37 PM)
42.41
-1.39 (-3.17%)
Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap201.45M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.83% |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.02 | ||
| Fwd PE | 8.87 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)1.15
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.92% | ||
| ROE | 12.81% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | 25.25% | ||
| GM | N/A | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.04
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.02 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | N/A | ||
| Quick Ratio | N/A | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-13.56%
EPS 3Y9.67%
EPS 5Y
EPS growth Q2Q
EPS Next Y-9.59%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)3.55%
Revenue growth 3Y5.61%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y